TP53 and cancer: Supplementary Figure S5C shows that TP53 and RB1 have higher levels of genomic alteration. The mutation count, TMB, fraction genome altered, aneuploidy score, MSIsensor score, radiation therapy, and Onc Tree code, and cancer type details also show significant difference in genome changes of FRGs (Supplementary Table S3).